Skip to main content
Erschienen in: Journal of Clinical Immunology 3/2018

04.04.2018 | Original Article

Complications Associated with Underweight Primary Immunodeficiency Patients: Prevalence and Associations Within the USIDNET Registry

verfasst von: Melanie A. Ruffner, Kathleen E. Sullivan, USIDNET Body Weight Group

Erschienen in: Journal of Clinical Immunology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The point prevalence of underweight status and obesity in primary immunodeficiency disease (PID) is unknown, despite the described associations between PID and weight loss and failure to thrive. The goal of this study is to estimate the prevalence of underweight status and obesity in PID patients and to investigate the associations between abnormal body weight and complications of PID.

Methods

Using the US Immunodeficiency Network (USIDNET), we performed a retrospective analysis of 653 pediatric (age 2 to 20 years) and 514 adult (age > 20) patient records with information on patient body mass index (BMI). Prevalence of underweight and obese status in PID patients was compared to data from the National Health and Nutrition Examination Survey (NHANES).

Results

After separating BMI data by year of entry to the database, we demonstrated that both adult and pediatric patients with PID had significantly higher prevalence of underweight patients in multiple years of analysis. Further examination of underweight patients by PID diagnosis revealed that underweight status in adults with CVID was associated with granulomatous disease as well as earlier age of CVID diagnosis. In the pediatric CVID cohort, underweight status was significantly associated with lymphopenia. Examination of obesity in pediatric and adult PID patients compared to NHANES database revealed only a single year when obesity in PID patients was significantly less prevalent. In other 2-year time intervals from 2005 to 2014, the prevalence of obesity was unchanged in children and adults.

Conclusions

These results quantify the prevalence of underweight status in PID in a North American population and demonstrate that whether as a result of weight loss or poor weight gain, underweight status is more prevalent in the PID population than in the general US population. The prevalence of obesity in PID patients was similar to that seen in the general population. This highlights the need for continued education on the association of low weight and PID.

Clinical Trial Registration

Literatur
2.
Zurück zum Zitat Lankisch P, Schiffner J, Ghosh S, Babor F, Borkhardt A, Laws HJ. The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules? J Clin Immunol. 2015;35:273–9.CrossRefPubMed Lankisch P, Schiffner J, Ghosh S, Babor F, Borkhardt A, Laws HJ. The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules? J Clin Immunol. 2015;35:273–9.CrossRefPubMed
3.
Zurück zum Zitat Subbarayan A, Colarusso G, Hughes MS, Gennery RA, Slatter M, Cant JA, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127:810–6.CrossRefPubMed Subbarayan A, Colarusso G, Hughes MS, Gennery RA, Slatter M, Cant JA, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatrics. 2011;127:810–6.CrossRefPubMed
4.
Zurück zum Zitat Reda SM, El-Ghoneimy DH, Afifi HM. Clinical predictors of primary immunodeficiency diseases in children. Allergy. Asthma. Immunol Res. 2013;5:88–95. Reda SM, El-Ghoneimy DH, Afifi HM. Clinical predictors of primary immunodeficiency diseases in children. Allergy. Asthma. Immunol Res. 2013;5:88–95.
5.
Zurück zum Zitat Guerrerio AL, Frischmeyer-Guerrerio PA, Lederman HM, Oliva-Hemker M. Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases. J Pediatr Gastroenterol Nutr. 2010;51:548–55.CrossRefPubMed Guerrerio AL, Frischmeyer-Guerrerio PA, Lederman HM, Oliva-Hemker M. Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases. J Pediatr Gastroenterol Nutr. 2010;51:548–55.CrossRefPubMed
6.
Zurück zum Zitat Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med Massachusetts Medical Society. 2010;362:314–9.CrossRef Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med Massachusetts Medical Society. 2010;362:314–9.CrossRef
7.
Zurück zum Zitat Barron MA, Makhija M, Hagen LE, Pencharz P, Grunebaum E, Roifman CM. Increased resting energy expenditure is associated with failure to thrive in infants with severe combined immunodeficiency. J Pediatr. 2011;159:628–32. e1 CrossRefPubMed Barron MA, Makhija M, Hagen LE, Pencharz P, Grunebaum E, Roifman CM. Increased resting energy expenditure is associated with failure to thrive in infants with severe combined immunodeficiency. J Pediatr. 2011;159:628–32. e1 CrossRefPubMed
8.
Zurück zum Zitat Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA American Medical Association. 2006;295:1549–55.CrossRef Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA American Medical Association. 2006;295:1549–55.CrossRef
9.
Zurück zum Zitat Ogden CL, Troiano RP, Briefel RR, Kuczmarski RJ, Flegal KM, Johnson CL. Prevalence of overweight among preschool children in the United States, 1971 Through. 1994. Ogden CL, Troiano RP, Briefel RR, Kuczmarski RJ, Flegal KM, Johnson CL. Prevalence of overweight among preschool children in the United States, 1971 Through. 1994.
10.
Zurück zum Zitat Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. Arch Pediatr Adolesc Med American Medical Association. 1995;149:1085.CrossRef Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. Arch Pediatr Adolesc Med American Medical Association. 1995;149:1085.CrossRef
11.
Zurück zum Zitat Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics. 1998;101. Troiano RP, Flegal KM. Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics. 1998;101.
12.
Zurück zum Zitat Jahn J, Spielau M, Brandsch C, Stangl GI, Delank KS, Bähr I, et al. Decreased NK cell functions in obesity can be reactivated by fat mass reduction. Obesity. 2015;23:2233–41.CrossRefPubMed Jahn J, Spielau M, Brandsch C, Stangl GI, Delank KS, Bähr I, et al. Decreased NK cell functions in obesity can be reactivated by fat mass reduction. Obesity. 2015;23:2233–41.CrossRefPubMed
13.
Zurück zum Zitat Laue T, Wrann CD, Hoffmann-Castendiek B, Pietsch D, Hübner L, Kielstein H. Altered NK cell function in obese healthy humans. BMC Obes. 2015;2:1.CrossRefPubMedPubMedCentral Laue T, Wrann CD, Hoffmann-Castendiek B, Pietsch D, Hübner L, Kielstein H. Altered NK cell function in obese healthy humans. BMC Obes. 2015;2:1.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Nieman DC, Nehlsen-Cannarella SI, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–60.PubMed Nieman DC, Nehlsen-Cannarella SI, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–60.PubMed
15.
Zurück zum Zitat Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631–6.PubMed Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631–6.PubMed
16.
Zurück zum Zitat Han SN, Jeon KJ, Kim MS, Kim H-K, Lee AJ. Obesity with a body mass index under 30 does not significantly impair the immune response in young adults. Nutr Res. 2011;31:362–9.CrossRefPubMed Han SN, Jeon KJ, Kim MS, Kim H-K, Lee AJ. Obesity with a body mass index under 30 does not significantly impair the immune response in young adults. Nutr Res. 2011;31:362–9.CrossRefPubMed
18.
Zurück zum Zitat Lee B-C, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance ☆. 2014 Lee B-C, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance ☆. 2014
19.
Zurück zum Zitat Sullivan KE, Puck JM, Notarangelo LD, Fuleihan R, Caulder T, Wang C, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol. 2014;34:428–35.CrossRefPubMedPubMedCentral Sullivan KE, Puck JM, Notarangelo LD, Fuleihan R, Caulder T, Wang C, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol. 2014;34:428–35.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. CDC growth charts for the United States: methods and development. Vital Health Stat. 2000;11(2002):1–190. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. CDC growth charts for the United States: methods and development. Vital Health Stat. 2000;11(2002):1–190.
22.
Zurück zum Zitat Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes. 1985;9:147–53.PubMed Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes. 1985;9:147–53.PubMed
23.
Zurück zum Zitat Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491–7.CrossRefPubMed Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491–7.CrossRefPubMed
24.
Zurück zum Zitat Ogden C, Carroll M, Lawman H, Fryar C, Kruszon-Moran D, Kit B, et al. Trends in obesity prevalence among children and adolescents in the united states, 1988–1994 through 2013–2014. JAMA Am Med Assoc; 2016; 2292–9. Ogden C, Carroll M, Lawman H, Fryar C, Kruszon-Moran D, Kit B, et al. Trends in obesity prevalence among children and adolescents in the united states, 1988–1994 through 2013–2014. JAMA Am Med Assoc; 2016; 2292–9.
27.
Zurück zum Zitat Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National Health and nutrition examination survey: sample design, 2011–2014. Vital Heal Stat. 2014;2:1–33. Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National Health and nutrition examination survey: sample design, 2011–2014. Vital Heal Stat. 2014;2:1–33.
28.
Zurück zum Zitat Curtin LR, Mohadjer LK, Dohrmann SM. National Health and Nutrition Examination Survey : sample design, 2007–2010. Vital Heal Stat. 2010;160:1–32. Curtin LR, Mohadjer LK, Dohrmann SM. National Health and Nutrition Examination Survey : sample design, 2007–2010. Vital Heal Stat. 2010;160:1–32.
29.
Zurück zum Zitat Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, et al. The National Health and nutrition examination survey: sample design, 1999-2006. Vital Health Stat. 2012;2:1–39. Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, et al. The National Health and nutrition examination survey: sample design, 1999-2006. Vital Health Stat. 2012;2:1–39.
31.
Zurück zum Zitat Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–91.CrossRefPubMed Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–91.CrossRefPubMed
32.
Zurück zum Zitat Al-Herz W, Moussa MAA. Survival and predictors of death among primary immunodeficient patients: a registry-based study. J Clin Immunol. 2012;32:467–73.CrossRefPubMed Al-Herz W, Moussa MAA. Survival and predictors of death among primary immunodeficient patients: a registry-based study. J Clin Immunol. 2012;32:467–73.CrossRefPubMed
33.
Zurück zum Zitat Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.CrossRefPubMed Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.CrossRefPubMed
34.
Zurück zum Zitat Boileau J, Mouillot G, Gérard L, Carmagnat M, Rabian C, Oksenhendler E, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun. 2011;36:25–32.CrossRefPubMed Boileau J, Mouillot G, Gérard L, Carmagnat M, Rabian C, Oksenhendler E, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun. 2011;36:25–32.CrossRefPubMed
36.
Zurück zum Zitat Nieman DC, Henson D a, Nehlsen-Cannarella SL, Ekkens M, Utter a C, Butterworth DE, et al. Influence of obesity on immune function. J Am Diet Assoc. 1999; 294–9. Nieman DC, Henson D a, Nehlsen-Cannarella SL, Ekkens M, Utter a C, Butterworth DE, et al. Influence of obesity on immune function. J Am Diet Assoc. 1999; 294–9.
37.
Zurück zum Zitat Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA American Medical Association. 1985;254:3187–9.CrossRef Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA American Medical Association. 1985;254:3187–9.CrossRef
38.
Zurück zum Zitat Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes Nature Publishing Group. 2012;36:1072–7.CrossRef Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes Nature Publishing Group. 2012;36:1072–7.CrossRef
Metadaten
Titel
Complications Associated with Underweight Primary Immunodeficiency Patients: Prevalence and Associations Within the USIDNET Registry
verfasst von
Melanie A. Ruffner
Kathleen E. Sullivan
USIDNET Body Weight Group
Publikationsdatum
04.04.2018
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 3/2018
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-018-0492-0

Weitere Artikel der Ausgabe 3/2018

Journal of Clinical Immunology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.